TVM Capital Life Science is a global venture capital firm specializing in multi-stage investments in life science sectors.
Location
Munich, Bavaria, DE
Founded
1995
TVM Capital Life Science is a global venture capital firm specializing in multi-stage investments within the life science sectors. With offices in Montreal, Canada, and Munich, Germany, the firm focuses on funding companies from the discovery phase to market-ready stages, as well as providing growth capital to profitable enterprises. Their investment rounds typically include Series A, B, C, and D, with investments ranging from early-stage to later-stage companies.
Notable portfolio companies include bluebird bio, which has raised $125 million, Rapid Micro Biosystems with $82.2 million, and Ubidyne with $58.5 million. TVM Capital Life Science is known for its strategic approach to transforming healthcare through funding novel and disruptive innovations. The firm offers significant value-add services, leveraging its extensive expertise to help develop and market breakthrough therapies and medical products that benefit patients and the healthcare system.
TVM Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
